Followers | 256 |
Posts | 28898 |
Boards Moderated | 0 |
Alias Born | 08/26/2015 |
Wednesday, August 24, 2016 1:42:09 PM
Their proprietary non opoid pain reliever is already patented. Their recent hire has huge NFL connections and should facilitate the marketing of this drug. Not sure what the possibilities are here honestly but I like the fact that they are monetizing multiple avenues which again is a rarity down here. And it won't take much revenue to change the valuation significantly. Non opoid medicines is also a huge revenue area right now.
Recent dilution completed. Cash on hand. Q much improved. Technicals very bullish.
Jmho
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM